Research programme: organ protection therapeutics - KBP Biosciences

Drug Profile

Research programme: organ protection therapeutics - KBP Biosciences

Alternative Names: Anti cancer therapeutics - KBP Biosciences; Anti fibrotics - KBP Biosciences; KBP-7018

Latest Information Update: 09 Sep 2014

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator KBP Biosciences
  • Class
  • Mechanism of Action Protein tyrosine kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Idiopathic pulmonary fibrosis
  • Research Cancer

Most Recent Events

  • 03 Sep 2014 Early research in Cancer in China (PO)
  • 03 Sep 2014 Preclinical trials in Idiopathic pulmonary fibrosis in China (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top